Acute Urinary Retention: Clinical Trials

9 trials for Acute Urinary Retention, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 3 recruiting, 2 not yet recruiting. 3 Phase 4, 2 Not applicable, 2 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 43Recruiting 2, Not yet recruiting 1
Not applicable2Completed 1, Recruiting 1
Phase 22Completed 1, Not yet recruiting 1
Phase 31Completed 1

Follow Acute Urinary Retention: new trials by email Literature Review of Acute Urinary Retention trials Research Report on Acute Urinary Retention

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of Teverelix DP on Prostate Volume, Urinary Function and Clinical Outcomes Following Acute Urinary Retention
Teverelix DP, Teverelix DP Placebo - Acute Urinary Retention, Benign Prostate Hypertrophy(BPH)
Phase 2Not yet recruitingAntev Ltd.1262026-09-012026-07-29
Tamsulosin Dose Escalation or Silodosin Switch Before Trial Without Catheter in BPH-Related Acute Urinary Retention
Tamsulosin 0.4 mg, Tamsulosin 0.8 mg, Silodosin 8 mg - Acute Urinary Retention, Benign Prostatic Hyperplasia
Phase 4RecruitingBeni-Suef University3782026-06-082026-06-16
Tamsulosin With or Without Tadalafil for Trial Without Catheter After Acute Urinary Retention Due to Benign Prostatic Hyperplasia
Tamsulosin, Tadalafil, Tadalafil Placebo - Acute Urinary Retention, Benign Prostatic Hyperplasia
Phase 4RecruitingBeni-Suef University3202026-06-082026-06-17
Perioperative Tamsulosin for Treating Voiding Dysfunction Following Prostate Biopsy
Tamsulosin 0.2mg - Acute Urinary Retention, LUTS(Lower Urinary Tract Symptoms)
Phase 4Not yet recruitingPeking University First Hospital18442026-02-012025-12-23
Early Versus Delayed Trial Without Catheter in Men With Acute Urinary Retention.
TWOC after 3 days, TWOC after 14 days - Acute Urinary Retention, Benign Prostate Obstruction
Not applicableRecruitingLiselot Ribbert4782025-08-212025-12-22
Prostatic Urethral Lift in Subject With Acute Urinary Retention
UroLift System Procedure - Acute Urinary Retention, Benign Prostatic Hyperplasia
Not applicableCompletedNeoTract, Inc.1012018-03-242021-07-16
Effects of Thoracic Epidural Anesthesia on Lower Urinary Tract Function
urodynamic procedure - Urodynamics, Acute Urinary Retention
CompletedInsel Gruppe AG, University Hospital Bern322008-10-012009-11-20
Alfuzosin for Treating Acute Urinary Retention
Alfuzosin, Placebo - Acute Urinary Retention
Phase 2CompletedSanofi1562006-02-012009-09-15
ALFAURUS : A DB Randomized Parallel Group Study of Alfuzosin 10mg OD vs Placebo in the Management of AUR in Patients With a 1st Episode Due to BPH
Alfuzosin - Prostatic Hyperplasia, Acute Urinary Retention
Phase 3CompletedSanofi8002001-05-012009-03-12

Narrower conditions

Prostatic Hyperplasia (6)  ·  Urinary Retention (2)  ·  Hypertrophy (1)  ·  Lower Urinary Tract Symptoms (1)  ·  Prostatic Diseases (1)

Broader conditions

Genital Diseases (6)  ·  Genital Diseases, Male (6)  ·  Male Urogenital Diseases (6)  ·  Urogenital Diseases (6)  ·  Prostatic Diseases (5)  ·  Female Urogenital Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Urination Disorders (2)  ·  Urologic Diseases (2)  ·  Pathological Conditions, Anatomical (1)  ·  Signs and Symptoms (1)  ·  Urological Manifestations (1)

Interventions

Tamsulosin (3)  ·  alfuzosin (2)  ·  Tadalafil (1)  ·  silodosin (1)

Sponsors

Beni-Suef University (2)  ·  Sanofi (2)  ·  Antev Ltd. (1)  ·  Insel Gruppe AG, University Hospital Bern (1)  ·  Liselot Ribbert (1)  ·  NeoTract, Inc. (1)  ·  Peking University First Hospital (1)

Countries

China (2)  ·  Egypt (2)  ·  Netherlands (1)  ·  Switzerland (1)  ·  United Kingdom (1)

Top investigators

Bart P.W. Witte, MD, PhD (1)  ·  Bruno Jolain (1)  ·  Fiona C Burkhard, Prod (1)  ·  Liselot L.A. Ribbert, MD, PhD candidate (1)  ·  Marco H. Blanker, Professor, MD, PhD (1)  ·  Mark Rochester (1)  ·  Neil Barber (1)  ·  Nikesh Thiruchelvam (1)  ·  Oliver Kayes (1)  ·  Rajesh Kavia (1)  ·  Toby Page (1)